AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
12 050 GBX
-0.87%
Market Closed
Updated:
May 6, 2024
AstraZeneca PLC
Selling, General & Administrative
|
AstraZeneca PLC
Selling, General & Administrative Peer Comparison
Comparables:
GSK
VRNA
INDV
HIK
DPH
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
Selling, General & Administrative
-$14.6B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-2%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Selling, General & Administrative
-£9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Selling, General & Administrative
-$50.4m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Selling, General & Administrative
-$530m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Selling, General & Administrative
-$544m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Selling, General & Administrative
-£207m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-11%
|
See Also
What is AstraZeneca PLC's Selling, General & Administrative?
Selling, General & Administrative
-14.6B
USD
-14.6B
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Selling, General & Administrative amounts to -14.6B USD.
What is AstraZeneca PLC's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-2%
-2%
Over the last year, the Selling, General & Administrative growth was -8%. The average annual Selling, General & Administrative growth rates for AstraZeneca PLC have been -16% over the past three years , -12% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
